By Professor Kerry-Anne Rye

Book Chapters

Cochran BJ; Manandhar B; Rye KA, 2022, 'HDL and Diabetes', in HDL Metabolism and Diseases, pp. 119 - 127, http://dx.doi.org/10.1007/978-981-19-1592-5_9

Rye K-A; Barter PJ, 2021, 'Lipid-Lowering Drugs', in Encyclopedia of Molecular Pharmacology, Springer International Publishing, pp. 1 - 8, http://dx.doi.org/10.1007/978-3-030-21573-6_6075-1

Rye K-A; Barter PJ, 2010, 'HDL Structure, Function, and Antiinflammatory Properties', in High Density Lipoproteins, Dyslipidemia, and Coronary Heart Disease, Springer New York, pp. 45 - 53, http://dx.doi.org/10.1007/978-1-4419-1059-2_5

Barter PJ; Rye KA, 2008, 'HDL and Atherosclerosis', in High-Density Lipoproteins: From Basic Biology to Clinical Aspects, pp. 491 - 505, http://dx.doi.org/10.1002/9783527625178.ch20

Siggins S; Rye KA; Olkkonen VM; Jauhiainen M; Ehnholm C, 2008, 'Human Plasma Phospholipid Transfer Protein (PLTP) - Structural and Functional Features', in High-Density Lipoproteins: From Basic Biology to Clinical Aspects, pp. 183 - 205, http://dx.doi.org/10.1002/9783527625178.ch8

Barter P; Baker P; Gamble J; Vadas M; Rye K-A, 2002, 'Anti-Inflammatory Properties of High Density Lipoproteins', in Medical Science Symposia Series, Springer US, pp. 95 - 101, http://dx.doi.org/10.1007/978-1-4615-1171-7_13

Barter PJ; Clay MA; Rye K-A, 'High Density Lipoproteins', in Plasma Lipids and Their Role in Disease, Taylor & Francis, pp. 85 - 85, http://dx.doi.org/10.4324/9780203304815_chapter_5

Rye K-A; Clay MA; Barter PJ, 'Overview of Plasma Lipid Transport', in Plasma Lipids and Their Role in Disease, Taylor & Francis, pp. 1 - 16, http://dx.doi.org/10.4324/9780203304815_chapter_1

Back to profile page